Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology

Yu-zhuo ZHANG; Rui-xiang ZENG; Yuan-shen ZHOU; Min-zhou ZHANG

doi:10.1007/s11655-021-2867-y

Your Location：

Home >

Browse articles >

Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology

Review | Updated：2021-09-01

- Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology
- Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology
- Chinese Journal of Integrative Medicine 2021年27卷第6期页码：470-480
- Affiliations：
  
  1.The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou (510120), China
  2.Department of Critical Care Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou(510120), China
  3.Division of Chest Pain Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou (510120), China
- Author bio：
  
  Prof. ZHANG Min-zhou, E-mail:minzhouzhang@aliyun.com
- Funds：
  
  the National Natural Science Foundation of China(81703848);Project of Administration of Traditional Chinese Medicine of Guangdong Province of China(20181126);the Special Clinical Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine(YN2018QL06);Hospital TCM Preparation Development Project(E44939)
- DOI：10.1007/s11655-021-2867-y
  中图分类号：
- 纸质出版日期：2021-06-01，
  
  录用日期：2020-08-09
Scan for full text
Yu-zhuo ZHANG, Rui-xiang ZENG, Yuan-shen ZHOU, 等. Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology[J]. Chinese Journal of Integrative Medicine, 2021,27(6):470-480.

Yu-zhuo ZHANG, Rui-xiang ZENG, Yuan-shen ZHOU, et al. Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology[J]. Chinese Journal of Integrative Medicine, 2021,27(6):470-480.
Yu-zhuo ZHANG, Rui-xiang ZENG, Yuan-shen ZHOU, 等. Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology[J]. Chinese Journal of Integrative Medicine, 2021,27(6):470-480. DOI： 10.1007/s11655-021-2867-y.

Yu-zhuo ZHANG, Rui-xiang ZENG, Yuan-shen ZHOU, et al. Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology[J]. Chinese Journal of Integrative Medicine, 2021,27(6):470-480. DOI： 10.1007/s11655-021-2867-y.

摘要

Abstract

Angina pectoris (AP) is the most common symptom of cardiovascular diseases

which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (宽胸气雾剂)

a compound preparation that consists of 5 traditional Chinese medicines:

Herba Asari

Rhizoma Alpiniae Officinarum

Lignum Santali Albi

Fructus Piperis Longi

and Borneolum

has been used in the treatment of AP for many years

exhibiting a significant curative effect and less side-effect. For the convenience and comprehensive understanding of KX Aerosol

this review systematically summarizes evidence on KX Aerosol in the treatment of AP including the pharmacological effects of its composition

clinical research

animal experiments

and network pharmacology prediction. Meanwhile

we highlight the research limitation of KX Aerosol at present. This review may guide the clinical application of KX Aerosol and further provide a reference for the research of AP.

关键词

Keywords

Kuanxiong Aerosolangina pectorispharmacologyclinical applicationnetwork pharmacology

references

BK Lee, HS Lim, WF Fearon, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation 2015;131:1054-1060.

TF Luescher. Revisiting angina pectoris with and without obstructive coronary artery disease. Eur Heart J 2018;39:2119-2122.

CP Benziger, GA Roth, AE Moran. The global burden of disease study and the preventable burden of NCD. Glob Heart 2016;11:393-397.

GA Mensah, DW Brown. An overview of cardiovascular disease burden in the United States. Health Aff (Millwood)2007;26:38-48.

R Ferrari, PG Camici, F Crea, et al. A 'diamond' approach to personalized treatment of angina. Nat Rev Cardiol 2018;15:120-132.

J Waltenberger. Chronic refractory angina pectoris:recent progress and remaining challenges. Eur Heart J 2017;38:2556-2558.

QN Yang, RN Bai, GJ Dong, et al. Effect of Kuanxiong Aerosol on patients with angina pectoris: a non-inferiority multi-center randomized controlled trial. Chin J Integr Med 2018;24:336-342.

SK Guo, KJ Chen, WL Weng, et al. Immediate effect of Kuan-xiong Aerosol in the treatment of anginal attacks.Planta Med 1983;47:116-116.

S Cai, X Wang, S Zhu, et al. Botanical origin of commercial samples of traditional Chinese drug Xixin (Herba Aasari).China J Chin Mater Med (Chin) 1996;21:712-760.

C Li, F Xu, C Cao, et al. Comparative analysis of two species of Asari Radix et Rhizoma by electronic nose, headspace GC-MS and chemometrics. J Pharm Biomed Anal 2013;85:231-238.

SJ Kim, CG Zhang, JT Lim. Mechanism of anti-nociceptive effects of Asarum sieboldii Miq. Radix: potential role of bradykinin, histamine and opioid receptor-mediated pathways. J Ethnopharmacol 2003;88:5-9.

S Yano, Y Suzuki, M Yuzurihara, et al. Antinociceptive effect of methyleugenol on formalin-induced hyperalgesia in mice. Eur J Pharmacol 2006;553:99-103.

JA Lee, MY Lee, CS Seo, et al. Asiasari sieboldii suppresses inflammatory mediators through the induction of hemeoxygenase-1 expression in RAW264.7 cells.Immunopharmacol Immunotoxicol 2012;34:15-20.

C Chen, D Spriano, T Lehmann, et al. Reduction of safrole and methyleugenol in Asari radix et rhizoma by decoction.Forsch Komplementarmed 2009;16:162-166.

LY Lin, KH Shen, XY Yeh, et al. Integrated process for production of galangal acetate, the "Wasabi-like" spicy compound, and analysis of essential oils of Rhizoma Alpinia officinarum (Hance) Farw. J Food Sci 2016;81:1565-1575.

WX Zhang, IC Chao, DJ Hu, et al. Comparison of antioxidant activity and main active compounds among different parts of Alpinia officinarum Hance using high-performance thin layer chromatography-bioautography. J AOAC Int 2019;102:726-733.

A Saeidinia, F Keihanian, AE Butler, et al. Curcumin in heart failure: a choice for complementary therapy? Pharmacol Res 2018;131:112-119.

MR Bergman, JR Teerlink, R Mahimkar, et al. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol 2007;292:H1847-H1860.

YH Tang, MW Bao, B Yang, et al. Curcumin attenuates left ventricular dysfunction and remodeling in rabbits with chronic heart failure. Chin J Cardiol (Chin) 2009;37:262-267.

M Namdari, A Eatemadi. Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artif Cells Nanomed Biotechnol 2017;45:731-739.

M Chakraborty, A Bhattacharjee, JV Kamath.Cardioprotective effect of curcumin and piperine combination against cyclophosphamide-induced cardiotoxicity. Indian J Pharmacol 2017;49:65-70.

MS Campbell, BS Fleenor. The emerging role of curcumin for improving vascular dysfunction: a review. Crit Rev Food Sci Nutr 2018;58:2790-2799.

LY Lin, CC Peng, XY Yeh, et al. Antihyperlipidemic bioactivity of Alpinia officinarum (Hance) Farw Zingiberaceae can be attributed to the coexistance of curcumin, polyphenolics, dietary fibers and phytosterols. Food Funct 2015;6:1600-1610.

S Ganjali, CN Bless, M Banach, et al. Effects of curcumin on HDL functionality. Pharmacol Res 2017;119:208-218.

VS Honmore, AD Kandhare, PP Kadam, et al.Diarylheptanoid, a constituent isolated from methanol extract of Alpinia officinarum attenuates TNF-alpha level in Freund's complete adjuvant-induced arthritis in rats. J Ethnopharmacol 2019;229:233-245.

VS Honmore, AD Kandhare, PP Kadam, et al. Isolates of Alpinia officinarum Hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies. Int Immunopharmacol 2016;33:8-17.

AA Aloud, V Chinnadurai, C Govindasamy, et al. Galangin, a dietary flavonoid, ameliorates hyperglycaemia and lipid abnormalities in rats with streptozotocin-induced hyperglycaemia. Pharm Biol 2018;56:302-308.

NS Younis. Doxorubicin-induced cardiac abnormalities in rats: attenuation via sandalwood oil. Pharmacology 2020;105:522-530.

M Qin, J Xie, H Zhou, et al. Experimental study of the effect of ethanol sediments from sandalwood tea on cardiovascular function and anti-fatigue. Genomics Appl Biol 2010;29:962-968.

R Kosuru, U Rai, S Prakash, et al. Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence. Eur J Pharmacol 2016;789:229-243.

BB Misra, S Dey. Comparative phytochemical analysis and antibacterial efficacy of in vitro and in vivo extracts from East Indian sandalwood tree (Santalum album L.). Lett Appl Microbiol 2012;55:476-486.

M Lv, KX Liu, SP Fu, et al. Pterostilbene attenuates the inflammatory reaction induced by ischemia/reperfusion in rat heart. Mol Med Rep 2015;11:724-728.

H Yuan, KL Houck, Y Tian, et al. Piperlongumine blocks JAK2-STAT3 to inhibit collagen-induced platelet reactivity independent of reactive oxygen species. PLoS One 2015;10:e0143964.

W Hang, ZX Yin, G Liu, et al. Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Oncogene 2018;37:3384-3398.

MS Krishna, B Joy, A Sundaresan. Effect on oxidative stress, glucose uptake level and lipid droplet content by apigenin 7, 4 '-dimethyl ether isolated from Piper longum L.J Food Sci Technol 2015;52:3561-3570.

DJ Son, SY Kim, SS Han, et al. Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling.Biochem Biophys Res Commun 2012;427:349-354.

L Zou, Y Zhang, W Li, et al. Comparison of chemical profiles, anti-inflammatory activity, and UPLC-Q-TOF/MS-based metabolomics in endotoxic fever rats between synthetic borneol and natural borneol. Molecules 2017;22:1446.

R Liu, L Zhang, X Lan, et al. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion:involvement of anti-oxidation and anti-inflammation through nuclear transcription factor kappa B signaling pathway.Neuroscience 2011;176:408-419.

LN Liang, YY Bai, YZ Tang, et al. Contribution of borneolum syntheticum to the intervention effect of Liuwei Dihuang Pill on experimental retinal degeneration. Chin J Integr Med 2018;24:442-447.

P Jiang, P Fu, L Xiang, et al. The effectiveness of borneol on pharmacokinetics changes of four ginsenosides in Shexiang Baoxin Pill in vivo. Biomed Chromatogr 2014;28:419-427.

T Yi, DD Tang, F Wang, et al. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Delivery 2017;24:422-429.

ZX Chen, QQ Xu, CS Shan, et al. Borneol for regulating the permeability of the blood-brain barrier in experimental ischemic stroke: preclinical evidence and possible mechanism. Oxid Med Cell Longev 2019;2019:2936737.

PL Wei, H Gu, S Guan, et al. Core prescription excavation of launched Chinese patent medicines for treating different syndromes of angina pectoris. China J Chin Mater Med(Chin) 2019;44:1041-1047.

YH Li, XP Sun, YQ Zhang, et al. The antithrombotic effect of borneol related to its anticoagulant property. Am J Chin Med 2008;36:719-727.

JC Silva-Filho, NNPM Oliveira, DDR Arcanjo, et al.Investigation of mechanisms involved in (-)-borneol-induced vasorelaxant response on rat thoracic aorta. Basic Clin Pharmacol Toxicol 2012;110:171-177.

HJ He, Q Shen, J Li. Effects of borneol on the intestinal transport and absorption of two P-glycoprotein substrates in rats. Arch Pharmacal Res 2011;34:1161-1170.

TJ Park, YS Park, TG Lee, et al. Inhibition of acetylcholine-mediated effects by borneol. Biochem Pharmacol 2003;65:83-90.

A Liuni, MC Luca, G Di Stolfo, et al. Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans. J Am Coll Cardiol 2011;57:93-98.

DF Song, JL Cao, QJ Ke. Clinical observation of Kuanxiong Aerosol in relieving angina Iectoris of coronary heart disease and effect on patients ECG. Chin Arch Tradit Chin Med (Chin) 2019;37:2519-2522.

LZ Li, GJ Dong, CJ Ge, et al. Effect of Kuanxiong Aerosol on coronary heart disease angina patients: a multicenter randomized controlled clinical study. Chin J Integr Med 2014;34:396-401.

QF Ma, T Zhang, N Li. Comparison of curative effect of Kuanxiong Aerosol and isosorbide dinitrate in treatment of angina pectoris of coronary heart disease. Clin Res Pract(Chin) 2017;2:19-20.

Cardiovascular Research Group of Xiyuan Hospital.Observation on analgesic effect of Kuanxiong Aerosol on acute attack of angina pectoris. J Tradit Chin Med (Chin)1973;10:14-16.

H Deng, XG Zhang. Clinical effect observation of Kuanxiong Aerosol in the treatment of unstable angina pectoris with cold accumulation and qi stagnation. Clin Res Pract (Chin)2017;2:124-125.

KJ Chen. Observation on the analgesic effect of Huan-Xiong Aerosol on anginal attack. J NIMA 1982;4:108-110.

DP Xu, BX Wu, Q Li, et al. Clinical study of Kuanxiong Aerosol's efficacy on exercise tolerance of patients with coronary heart disease complicated with chest tightness/pain after activities.Chin J Integr Tradit West Med (Chin) 2020;40:287-289.

SH Wang. Enlightenment of Kuanxiong Aerosol on chest obstruction. Chin J Integr Med Cardiocerebrovasc Dis (Chin)2020;18:193-194.

JF Beltrame. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X. Eur Heart J 2005;26:946-948.

GP Zhang, HN Xie. Clinical observation on 65 cases of cardiac syndrome X treated with Kuanxiong Aerosol. Chin J Integr Med Cardiocerebrovasc Dis (Chin) 2018;16:3561-3563.

JG Liu, J Cui, ZQ Liu. Effect of Kangxin Zhitong Ointment on experimental microcirculation disturbance. Chin J Microcirc (Chin) 1995;5:43.

AL Hopkins. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4:682-690.

JL Ru, P Li, JN Wang, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014;6:13.

S Kim, J Chen, T Cheng, et al. PubChem 2019 update:improved access to chemical data. Nucleic Acids Res 2019;47:D1102-D1109.

A Daina, O Michielin, V Zoete. SwissTargetPrediction:updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 2019;47:W357-W364.

DS Wishart, YD Feunang, AC Guo, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 2018;46:D1074-D1082.

YX Wang, S Zhang, FC Li, et al. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res 2020;48:D1031-D1041.

J Pinero, A Bravo, N Queralt-Rosinach, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res 2017;45:D833-D839.

G Stelzer, N Rosen, I Plaschkes, et al. The GeneCards Suite:from gene data mining to disease genome sequence analyses.Current protocols in bioinformatics 2016;54:31-33.

C von Mering, M Huynen, D Jaeggi, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 2003;31:258-261.

DW Huang, BT Sherman, RA Lempicki. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.

BJ Wang, GJ Dong, JG Liu, et al. The relieving effects of Kuanxiong Aerosol on angina pectoris and its influences on endothelial function index in patients with coronary heart disease. J Emerg Tradit Chin Med (Chin) 2015;24:2175-2178.

LJ Ignarro. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 2002;53:503-514.

JO Lundberg, MT Gladwin, E Weitzberg. Strategies to increase nitric oxide signalling in cardiovascular disease.Nat Rev Drug Discovery 2015;14:623-641.

F Hofmann. The cGMP system: components and function.Biol Chem 2020;401:447-469.

YZ Zhao, PM Vanhoutte, SWS Leung. Vascular nitric oxide:beyond eNOS. J Pharmacol Sci 2015;129:83-94.

BH Wu, GW Wang, X Lu, et al. Network pharmacology-based analysis on pharmacological mechanism of Kuanxiong Aerosol for angina pectoris therapy. Chin J Integr Tradit West Med (Chin) 2019;39:1483-1493.

MW Radomski, RMJ Palmer, S Moncada. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-1058.

MW Radomski, RMJ Palmer, S Moncada. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.Biochem Biophys Res Commun 1987;148:1482-1489.

R Esse, M Barroso, IT de Almeida, et al. The contribution of homocysteine metabolism disruption to endothelialdysfunction:state-of-the-art. Int J Mol Sci 2019;20:867.

TV Stepanova, AN Ivanov, NE Tereshkina, et al. Markers of endothelial dysfunction: pathogenetic role and diagnostic significance. Klin Lab Diagn 2019;64:34-41.

A Koller, A Szenasi, G Dornyei, et al. Coronary microvascular and cardiac dysfunction due to homocysteine pathometabolism; a complex therapeutic design. Curr Pharm Des 2018;24:2911-2920.

LH Liu, Z Guo, M Feng, et al. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells. Cell Physiol Biochem 2012;30:1413-1422.

MF Yuyun, LL Ng, GA Ng. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease.Where are we with therapy? Microvasc Res 2018;119:7-12.

M Houde, L Desbiens, P D'Orleans-Juste.Endothelin-1:biosynthesis, signaling and vasoreactivity. London:Academic Press Ltd-Elsvier Science Ltd; 2016:143-175.

AP Davenport, KA Hyndman, N Dhaun, et al. Endothelin.Pharmacol Rev 2016;68:357-418.

PM Ridker, JG MacFadyen, BM Everett, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet 2018;391:319-328.

BK Martinez, CM White. The emerging role of inflammation in cardiovascular disease. Ann Pharmacother 2018;52:801-809.

M Barroso, D Kao, HJ Blom, et al. S-adenosylhomocysteine induces inflammation through NFκB: a possible role for EZH2 in endothelial cell activation. Biochim Biophys Acta Mol Basis Dis 2016;1862:82-92.

O Yousuf, BD Mohanty, SS Martin, et al. High-sensitivity C-reactive protein and cardiovascular disease a resolute belief or an elusive link? J Am Coll Cardiol 2013;62:397-408.

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Ethnopharmacology, Phytochemistry, Pharmacology, Toxicology and Clinical Applications of Radix Astragali

Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via A Network Pharmacology Approach

Advanced Studies on Rhizoma Dioscoreae Collettii

Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini

Clean-DM1, a Korean Polyherbal Formula, Improves High Fat Diet-Induced Diabetic Symptoms in Mice by Regulating IRS/PI3K/AKT and AMPK Expressions in Pancreas and Liver Tissues